Google+ Facebook Twitter Twitter

MRI for prostate cancer screening?

A new clinical study will test for the first time if MRI scans can be used for population screening to detect prostate cancer more accurately.

MRI for prostate cancer screening?

The current prostate-specific antigen (PSA) test is considered too unreliable for population screening.

But researchers will investigate whether MRI could be used to screen men to pick up cancers earlier and more reliably, potentially helping to save lives.

They will also study whether, combined with cutting-edge techniques – including genomics and machine learning – MRI scans can replace prostate biopsies.

A group, led by Mark Emberton from University College London, working with King’s College London, Imperial College London and 12 industry partners, aims to recruit 1000 men with medium- to high-risk cancers to find out if MRI can be combined with other high-tech diagnostic tests to predict progression.

The study is being launched with funding of £4.1m from the Medical Research Council and £1m from Cancer Research UK.

Related Articles

Changes ahead

Role development, workforce strategies and professional qualifications... Sarah May looks back at 2019 and forward to the New Year. 


Efficient regulation

A more consistent and transparent regulatory system can only be for the good, writes Sarah May.  


Imaging with LEGO

Researchers have come up with an inexpensive, automated way to image biological samples – using the children’s toy, LEGO.


My Lab: dynamic histopathology service

Trainee Specialist Biomedical Scientist Megan Clarkson gives a guided tour of her laboratory at Salford Royal NHS Foundation Trust.